Leaked EU pharma strategy focuses on ‘unmet needs’

Commission wants academia, regulators and patients to weigh in on early stages of drug R&D

A leaked draft copy of the European Commission’s forthcoming pharmaceutical strategy puts much of the focus on meeting patients’ “unmet needs” by changing R&D priorities.

“Currently, investment does not necessarily focus on the greatest unmet needs due to the absence of commercial interest or limitations of the science,” says the draft, published by the news website Euractiv on 24 November.